Postoperative Nausea and Vomiting Clinical Trial
Official title:
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
| NCT number | NCT02625181 |
| Other study ID # | 151750 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 2016 |
| Est. completion date | November 30, 2017 |
| Verified date | March 2019 |
| Source | Vanderbilt University Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.
| Status | Completed |
| Enrollment | 27034 |
| Est. completion date | November 30, 2017 |
| Est. primary completion date | November 2, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - All adult patients (18 years and older) that are scheduled for an elective surgical procedure under general anesthesia Exclusion Criteria: - Patients undergoing emergency surgery or organ transplantation - Patients that are transferred directly to the Intensive Care Unit after the end of the procedure - Patients that die intraoperatively - Procedures that only require a sedative level of anesthesia |
| Country | Name | City | State |
|---|---|---|---|
| United States | Vanderbilt University Medical Center | Nashville | Tennessee |
| Lead Sponsor | Collaborator |
|---|---|
| Vanderbilt University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Adherence to PONV Guidelines | PONV guideline adherence: percentage of patients who received the exact number of prophylactic interventions for PONV that were recommended by the decision support. | A specific time frame on the day of surgery: the start of admission at the holding room to the end of the anesthetic case | |
| Secondary | PONV Incidence: Number of Participants With Postoperative Nausea and Vomiting | The occurrence of PONV, as defined by the administration of antiemetics in the PACU between admission to PACU and discharge from PACU. | PACU recovery period | |
| Secondary | The Number of Prophylactic Interventions for PONV | the absolute number of prophylactic interventions applied between the admission of the patient in the holding room until admission to the PACU. | A specific time frame on the day of surgery: from the start of admission at the holding room to the end of the anesthetic case | |
| Secondary | Time to Discharge From the Postanesthesia Care Unit (PACU) | This is the number of minutes from admission to the PACU until discharge, assessed up to 2 days | A specific time frame on the day of surgery: from the start of admission to the PACU to discharge from the PACU |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
| Completed |
NCT03139383 -
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
|
N/A | |
| Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
| Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
| Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
| Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
| Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
| Recruiting |
NCT05375721 -
Prevention of PONV With Traditional Chinese Medicine
|
N/A | |
| Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
| Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
| Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
| Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
| Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
| Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
| Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
| Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
| Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
| Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
| Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
| Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 |